GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

tisotumab vedotin   Click here for help

GtoPdb Ligand ID: 11719

Synonyms: HuMax-TF-ADC | TF-011-MMAE | tisotumab vedotin-tftv | Tivdak®
Approved drug
tisotumab vedotin is an approved drug (FDA (2021))
Compound class: Antibody
Comment: Tisotumab vedotin is an antibody-drug conjugate (ADC) of an anti-factor 3 monoclonal antibody that is conjugated to the antineoplastic agent monomethyl auristatin E (MMAE; PubChem CID 11542188) [1]. Tisotumab vedotin causes adverse events that are associated with disrupted coagulation [4].
Classification Click here for help
Compound class Antibody
Approved drug? Yes. EU EMA (2025)  |  US FDA (2021)
International Nonproprietary Names Click here for help
INN number INN
10148 tisotumab vedotin
Synonyms Click here for help
HuMax-TF-ADC | TF-011-MMAE | tisotumab vedotin-tftv | Tivdak®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 571
Other databases
GtoPdb PubChem SID 458923754
Search PubMed clinical trials tisotumab vedotin
Search PubMed titles tisotumab vedotin
Search PubMed titles/abstracts tisotumab vedotin